Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиVoyager Therapeutics Мультипликаторы 2011-2024 | VYGR
Мультипликаторы по годам Voyager Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
2.9 | -6.1 | -1.5 | 7.6 | -9.1 | -3.8 | -8.1 | -7.3 | -9.0 | - | - | - | - |
P/S |
1.5 | 6.9 | 2.9 | 1.6 | 3.8 | 44.3 | 56.3 | 20.7 | 15.4 | - | - | - | - |
EPS |
3.1 | -1.2 | -1.9 | 1.0 | -1.2 | -2.8 | 2.6 | 1.6 | 9.1 | 27.8 | - | - | - |
EV (Enterprise Value) |
432 млн | 284 млн | 89.1 млн | 283 млн | 566 млн | 421 млн | 590 млн | 312 млн | 295 млн | 3.31 млн | 3.85 млн | - | - |
EBITDA per Share |
2.94 | -1.16 | -1.82 | 0.84 | -1.36 | -2.77 | -2.62 | -1.61 | -0.788 | - | - | - | - |
EV/EBITDA |
-0.8 | 5.7 | -6.4 | -3.3 | -7.7 | -6.4 | -12.0 | - | - | - | - | ||
PEG |
-0.02 | 0.05 | 0.02 | -0.96 | -0.16 | 0.92 | 0.12 | 2.08 | -0.15 | - | - | - | - |
P/B |
1.6 | 4.8 | 1.1 | 1.8 | 4.0 | 7.3 | 4.3 | 2.2 | 1.6 | - | - | - | - |
P/CF |
5.0 | -22.6 | -2.0 | -2.9 | 9.7 | -16.7 | -8.7 | -6.2 | 6.6 | - | - | - | - |
ROE % |
56.00 | -78.63 | -74.90 | 23.81 | -43.81 | -190.09 | -52.74 | -29.57 | -17.55 | - | - | - | - |
ROA % |
37.67 | -29.12 | -36.73 | 14.05 | -12.29 | -49.87 | -38.32 | -21.20 | -12.93 | - | - | - | - |
ROCE % |
51.63 | -86.14 | -77.45 | 17.74 | -18.54 | -62.67 | -42.63 | -23.50 | -9.85 | - | - | - | - |
Current Ratio |
3.1 | 1.6 | 2.0 | 2.4 | 4.0 | 5.1 | 10.8 | 13.0 | 8.2 | - | - | - | - |
DSO |
58.8 | 1.8 | 0.5 | 0.3 | 66.3 | 9.6 | 4.4 | 59.1 | 8.7 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
58.8 | 1.8 | 0.5 | 0.3 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
58.8 | 1.8 | 0.5 | 0.3 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Voyager Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.59 | -0.51 | 3.05 | - | 0.46 | -0.5 | -0.56 | - | -0.67 | -0.8 | -0.58 | - | 2.3 | -0.23 | -0.66 | -0.34 | -0.41 | 0.3 | -0.81 | -0.7 | -0.63 | -0.8 | -0.63 | -0.4 | -0.89 | -0.73 | -0.65 | 0.57 | -0.35 | -0.37 | -0.29 | 0.67 | -5.25 | -5.94 | -15.79 | 6.58 | -6.45 | 8.11 | 6.93 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | 3.05 | - | 0.51 | -0.51 | -0.49 | - | -0.57 | -0.76 | -0.65 | - | 2.35 | -0.19 | -0.64 | -0.37 | -0.43 | 0.29 | -0.86 | -0.72 | -0.61 | -0.77 | -0.65 | -0.39 | -0.85 | -0.69 | -0.67 | -0.54 | -0.39 | -0.37 | -0.29 | -0.3 | -3 | -3.25 | -4.69 | -5.52 | -5.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
53.40 | 90.17 | 69.55 | -37.78 | -66.54 | -117.37 | -112.83 | -71.90 | -16.42 | 67.81 | 89.43 | 34.13 | 21.49 | -49.06 | -32.23 | -43.81 | -79.69 | -108.29 | -174.49 | -190.09 | -150.40 | -124.13 | -83.22 | -52.74 | -54.71 | -43.91 | -36.70 | -29.57 | -23.99 | -19.69 | -15.12 | -18.46 | 11.71 | 33.25 | 35.55 | 44.18 | 19.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
30.72 | 49.16 | 46.69 | -9.36 | -22.97 | -36.72 | -51.15 | -37.14 | -4.41 | 41.92 | 53.03 | 20.13 | 16.59 | -20.37 | -13.91 | -12.29 | -21.47 | -28.70 | -46.27 | -49.87 | -43.56 | -44.75 | -40.55 | -38.32 | -39.65 | -31.74 | -26.44 | -21.20 | -17.30 | -14.27 | -11.04 | -13.60 | -54.96 | -88.09 | -86.39 | -80.04 | -34.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
45.21 | 80.05 | 60.57 | -42.28 | -71.04 | -117.90 | -111.51 | -73.41 | -18.64 | 64.90 | 84.94 | 33.12 | 19.29 | -53.38 | -38.33 | -51.93 | -87.96 | -115.60 | -180.15 | -196.13 | -155.48 | -127.37 | -85.95 | -53.61 | -54.58 | -44.79 | -37.96 | -30.38 | -24.60 | -19.35 | -14.62 | -11.98 | 14.01 | 33.93 | 36.28 | 39.14 | 17.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.5 | 2.7 | 2.8 | 1.6 | 1.8 | - | 1.5 | 2.0 | 1.9 | 2.1 | 2.3 | 2.4 | 2.4 | 2.4 | 2.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 3.7 | 3.7 | 3.7 | 3.7 | 3.5 | 3.5 | 3.5 | 3.5 | 3.8 | 3.8 | 3.8 | 3.8 | 1.1 | 1.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | 7.6 | - | 11.1 | - | 1.1 | - | - | - | 0.7 | - | - | - | 1.2 | 0.7 | - | - | 5.4 | 14.0 | - | - | 5.9 | 0.9 | - | - | 10.6 | 6.5 | - | - | 3.9 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | 7.6 | - | 11.1 | - | 1.1 | - | - | - | 0.7 | - | - | - | 1.2 | 0.7 | - | - | 5.4 | 14.0 | - | - | 5.9 | 0.9 | - | - | 10.6 | 6.5 | - | - | 3.9 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | 7.6 | - | 11.1 | - | 1.1 | - | - | - | 0.7 | - | - | - | 1.2 | 0.7 | - | - | 5.4 | 14.0 | - | - | 5.9 | 0.9 | - | - | 10.6 | 6.5 | - | - | 3.9 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD